Dermatology Service, Hospital de Clínicas de Porto Alegre (HCPA), Brazil.
Exp Dermatol. 2011 Nov;20(11):890-3. doi: 10.1111/j.1600-0625.2011.01332.x. Epub 2011 Sep 6.
Several germline mutations and sequence variants in cancer predisposition genes have been described. Among these, the CDKN2A p.A148T variant appears to be frequent in patients with melanoma, at least in certain ethnic groups. In this case-control study, we evaluated 127 patients with cutaneous melanoma and 128 controls from Southern Brazil, the region with the highest melanoma incidence rates in the country. Using PCR-RFLP, we demonstrate that CDKN2A p.A148T variant was significantly more frequent in patients with melanoma than in controls (12.6% vs 3.9%; P=0.009). There was no association between presence of the polymorphism and tumor thickness, site of the primary tumor, melanoma subtype, age at diagnosis, quantitative and qualitative number of nevi. Patients with a positive family of history for other cancers were particularly prone to carry the CDKN2A p.A148T allele. All patients with p.A148T-positive melanoma reported European ancestry, especially German, and this was confirmed using a panel of ancestry-informative INDELs. Our data suggest that CDKN2A p.A148T is a melanoma susceptibility allele in Southern Brazil and is particularly common in patients with melanoma of predominantly European ancestry.
已经描述了几种癌症易感性基因的种系突变和序列变异。其中,CDKN2A p.A148T 变异似乎在黑色素瘤患者中很常见,至少在某些种族群体中是如此。在这项病例对照研究中,我们评估了来自巴西南部的 127 名皮肤黑色素瘤患者和 128 名对照者,该地区是该国黑色素瘤发病率最高的地区。通过 PCR-RFLP,我们证明 CDKN2A p.A148T 变异在黑色素瘤患者中明显比对照者更为常见(12.6%比 3.9%;P=0.009)。该多态性的存在与肿瘤厚度、原发性肿瘤部位、黑色素瘤亚型、诊断时的年龄、痣的数量和质量均无关联。有其他癌症阳性家族史的患者特别容易携带 CDKN2A p.A148T 等位基因。所有携带 p.A148T 阳性黑色素瘤的患者均报告有欧洲血统,尤其是德国血统,这一点通过一组与祖先有关的 INDELs 得到了证实。我们的数据表明,CDKN2A p.A148T 是巴西南部的黑色素瘤易感等位基因,尤其常见于主要具有欧洲血统的黑色素瘤患者。